3 ms·
Since I work in the biopharma industry, I've had a lot of people ask "This company is making [vaccine, test, treatment] for Coronavirus. They'll probably make
by refurb 7y ago
Since I work in the biopharma industry, I've had a lot of people ask "This company is making [vaccine, test, treatment] for Coronavirus. They'll probably make a lot of money, right?".
My answer is "probably not". This is too big a public health issue. Any company that slows down the process in the name of business is going to find themselves in a PR storm and likely government action will make them give up any control they might have.
- altcognito 7y agoThey would only get the most positive press they've ever had in their history. Health care companies seem allergic to goodwill.
- Ididntdothis 7y agoI work in medical devices which is similar and I think they will make a lot of money. They probably can’t push it as far as they tend to do with some cancer drugs but they certainly won’t suffer.
- refurb 7y agoMaybe I should rephrase. It's not like they'll lose money, but they'll make much less than one would expect for such an important product!